Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Antonio Gonnella
Phase II Study of Sorafenib in Patients With Sunitinib-Refractory Metastatic Renal Cell Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Related publications
Successful Treatment With Sorafenib for Sunitinib-Refractory Metastatic Papillary Renal Cell Carcinoma: Potential Impact of Raf Overexpression on Predicting the Efficacy of Sorafenib
IJU Case Reports
A Phase II Trial of Sunitinib in Patients With Renal Cell Cancer and Untreated Brain Metastases
Clinical Genitourinary Cancer
Oncology
Urology
A Phase I, Open-Label Study of Trebananib Combined With Sorafenib or Sunitinib in Patients With Advanced Renal Cell Carcinoma
Clinical Genitourinary Cancer
Oncology
Urology
Phase I Study of Oral Lenalidomide in Patients With Refractory Metastatic Cancer
Journal of Clinical Pharmacology
Pharmacology
Phase I Trial of Sunitinib and Temsirolimus in Metastatic Renal Cell Carcinoma
Clinical Genitourinary Cancer
Oncology
Urology
Genetic Polymorphisms Associated With a Prolonged Progression-Free Survival in Patients With Metastatic Renal Cell Cancer Treated With Sunitinib
Clinical Cancer Research
Cancer Research
Oncology
Sunitinib in the Treatment of Metastatic Renal Cell Carcinoma
Therapeutic Advances in Urology
Urology
SWOG 0514: A Phase II Study of Sorafenib in Patients With Unresectable or Metastatic Gallbladder Carcinoma and Cholangiocarcinoma
Investigational New Drugs
Oncology
Pharmacology
Phase I Trial of Sorafenib in Combination With Gefitinib in Patients With Refractory or Recurrent Non Small Cell Lung Cancer
Clinical Cancer Research
Cancer Research
Oncology
